The RheumNow Week in Review – 3 February 2017 Save
Dr. Jack Cush reviews this week's highlights from RheumNow.
- Infliximab given 4 wks before TKA or THA did not increase risk of hospitalized or post-op joint infections https://t.co/0PPLyNnNP5
- Chemokine CXCL10 highly correlates w/ DAS28, CDAI, SJC, CRP & ESR in pts w/ early untreated RA. Potential Biomarker? https://t.co/TLJbHwx54H
- Sarilumab (anti-IL-6) "Kevzara" approved by Health Canada for the Rx of RA. Dose 200 mg sc EOW. Let IL6 Wars begin! https://t.co/ALqovaE7o2
- Risk of incident gout 70 fold higher w/ SUA >10; Risk of recurrent gout is 5 fold higher if SUA >9; https://t.co/GznuJ8tq1l
- A study of 1305 pts shows Psoriatic Arthritis has a 43% higher risk of diabetes. Risk linked to tender Jts and ESR. https://t.co/XdP3IXnJ3G
- NHS: Post-Menopausal women have a 2fold higher risk of seronegative RA (vs. Post-menopause). Menopause before age 44yrs HR= 2.4 https://t.co/67tKyqBcyw
- 1 million Americans will have hip or knee replacement; but 1/12 hosp w/ complications, and theres no predictive tool https://t.co/Zgr5ejKl7Q
- Psoriasis and Psoriatic arthritis pts have a 2 fold increased risk of fracture (including vertebral Fx). https://t.co/kobdkEZGQn
- After 1st yr RA pts switch from Remicade to CT-P13 (Inflectra) had same ACR 20/50/70, anti-Drug Abs INTERCHANGEABLE! https://t.co/xoUAX6Qls9
- Metanalysis of lupus & Rx adherence shows 43-75%, of patients are non-adherent, & 1/3 stop theray after 5 yrs. https://t.co/XdwdVUNPoA
- Study of Pregnant Psoriatic arthritis women shows skin tends to do well, but joint may worsen in upto 40%. https://t.co/0KyHJ3hwTf
- Recent review of Humira safety in >15k pts shows only 3 congenital anomalies (~4%) that was less than controls (~5%) https://t.co/L4HUf1nshL
- Among 103 SLE pts ~10% had "Rhupus" polyarthritis; they had less renal, but more joints, erosions, hi ESR/CRP levels https://t.co/ZA4szjXbFT
- Gout is Undermanaged
- Limited Efficacy of NSAIDs in Spondyloarthritis
- Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
- Uncertain efficacy of Pneumococcal vaccine
ADD THE FIRST COMMENT
Disclosures
The author has received compensation as an advisor or consultant on this subject
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.